Pliant's IPO keeps biotech close to its 2019 pace, a telling statistic given the coronavirus pandemic has thrown public markets into turmoil since early March. IPO activity has shown signs of picking up, too, with multiple biotechs either recently filing offerings or closing in on pricing them. Chinese firm Legend Biotech could hold the sector's biggest IPO of the year on Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,